logo
Plus   Neg
Share
Email

Seattle Genetics Responds To Daiichi Sankyo's Declaratory Judgment Complaint

Seattle Genetics, Inc. (SGEN) on Tuesday issued a response to Daiichi Sankyo's filing of a Declaratory Judgment action alleging Seattle Genetics is not entitled to intellectual property rights under their collaboration for the development of antibody-drug conjugates or ADCs.

Seattle Genetics noted that, under the agreement entered into between the two parties in 2008, the ADC technology used in Daiichi Sankyo's metastatic breast cancer drug candidate (DS-8201, [Fam-] trastuzumab deruxtecan) among other product candidates, rightfully belongs to Seattle Genetics.

"The linker and other ADC technology used in these drug candidates are improvements to Seattle Genetics' pioneering ADC technology, the ownership of which are automatically assigned to Seattle Genetics under the terms of the agreement," the company noted.

Seattle Genetics said it has been abiding by the dispute resolution provisions under the agreement to pursue its legal rights. By filing this lawsuit, Daiichi Sankyo has circumvented the process underway between the parties pursuant to these provisions.

Seattle Genetics said it would protect intellectual property rights as it continues to find revolutionary new treatments for cancer patients.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>